Lydall Names New Vice President, Human Resources

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Lydall Names New Vice President, Human Resources

MANCHESTER, Conn., Sept. 30, 2013 (GLOBE NEWSWIRE) -- Lydall, Inc. (NYSE: LDL ) today announced that William M. Lachenmeyer has been appointed Vice President, Human Resources for Lydall, Inc. ("Lydall" or "the Company"). Mr. Lachenmeyer replaces Mona G. Estey who has served Lydall in various human resource roles for 36 years, most recently as Vice President, Human Resources since April 2000. Ms. Estey has elected to resign her position at this time to pursue other interests as she transitions into voluntary retirement.

Mr. Lachenmeyer's most recent position was with Smith & Wesson, a publicly-traded manufacturer of firearms, as its Vice President Human Resources. In this capacity, Mr. Lachenmeyer led the human resource, employee benefits, security and environmental functions, and served as a strategic partner to the businesses to help attract, retain, and strengthen Smith & Wesson's talent. He also worked closely with the CEO and members of the compensation committee of the board to align executive compensation programs with the public company environment.

Prior to his tenure at Smith & Wesson, Mr. Lachenmeyer held several director-level human resource positions at Omnova Solutions, Inc. He also held human resource roles of increasing responsibilities with Alcoa Fastening Systems and Colgate-Palmolive Company. Mr. Lachenmeyer earned a B.S. in Business Administration from State University of New York, and a Masters of Public Management from Carnegie Mellon University.

Commenting on Mr. Lachenmeyer's appointment, Dale G. Barnhart, President and Chief Executive Officer of the Company, said: "We are delighted to have Bill join Lydall as he will be a valuable addition to our executive leadership team. He brings a strong combination of talent management and leadership experience that will be an asset to Lydall as we execute our growth strategy." Regarding Ms. Estey's resignation, Mr. Barnhart commented, "On behalf of the Company, its employees, directors and shareholders, I extend to Ms. Estey our best wishes and thanks for her many valued contributions over her long career at Lydall."

Lydall, Inc. is a New York Stock Exchange listed company, headquartered in Manchester, Connecticut. The Company, with operations in the U.S., France, the Netherlands and Germany and offices in the U.S., Europe, and Asia, manufactures specialty engineered products for the thermal/acoustical and filtration/separation markets. For more information, visit http://www.lydall.com . Lydall, Inc. is a registered trademark of Lydall, Inc. in the U.S. and other countries. All product names are trademarks of Lydall, Inc. or Charter Medical, Ltd.

For further information: David D. Glenn Director of Business Development and Investor Relations Telephone 860-646-1233 Facsimile 860-646-4917 www.lydall.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 19

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 11

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 14

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 9

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 14

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 16

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 14

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 15

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading

Top 5 Most Recently Viewed Articles

China's Strategic Response to US Tariff Increases Affects Companies

Updated Category News Views 329

China's Response to Increased US Tariffs China has taken a strong stand against recent tariff increases implemented by the U.S., positioning itself as a formidable player in international trade. This reaction includes reciprocal tariffs on a range of American products, sanctions on U.S. companies, and plans to address these issues through the World Trade Organization....

Continue Reading
Clearwater Living Achieves Energy Star Certification for 2025

Updated Category News Views 189

Clearwater Living Earns Energy Star Certification Clearwater Living, a reputable real estate and property management company, has made significant strides in energy efficiency. The company announced that three of its Arizona communities have been awarded the prestigious Energy Star certification, recognizing their superior performance in energy management. This honor...

Continue Reading
e.l.f. Beauty Champions Empowerment with Amanda Nguyen Partnership

Updated Category News Views 493

e.l.f. Beauty Celebrates Women's Empowerment with Amanda Nguyen e.l.f. Beauty (NYSE: ELF) has made an exciting announcement about its collaboration with Amanda Nguyen, a prominent activist, Nobel Peace Prize nominee, and astronaut. This partnership aims to combine the magic of beauty with the powerful message of empowerment, demonstrating e.l.f.'s dedication to making...

Continue Reading
Lifeway Foods and Danone Forge New Path with Cooperation Agreement

Updated Category News Views 331

Lifeway Foods and Danone Collaboration Announcement Lifeway Foods, Inc. (NASDAQ: LWAY) has taken a significant step forward by entering into a Cooperation Agreement with Danone North America PBC. This strategic collaboration aims to bolster the organizational structure of Lifeway while ensuring stability in the company’s governance. Board Refreshment Strategy As...

Continue Reading
Rémy Cointreau Faces Sales Challenges Amid Revised Forecasts

Updated Category News Views 263

Rémy Cointreau's Recent Sales Decline Rémy Cointreau's shares recently experienced a notable decline, reflecting the company's challenging financial landscape. Following a recent forecast cut, the company reported disappointing sales results for the second quarter, culminating in a sense of urgency among analysts and investors alike. Revised Outlook and Sales...

Continue Reading